


The fundamentals in the Pharmaceutical Outsourcing industry remain solid as the sector continues to benefit from a record number of drugs under development and a rise in research and development initiatives targeting rare diseases. Available for download below, Capstone Headwaters’ Q3 Pharmaceutical Outsourcing report includes:
To learn more about the contents of the report, please contact Eric Williams.